Genomic Cancer Testing Market Is Estimated To Witness High Growth Owing To Increasing Prevalence of Cancer
The global Genomic Cancer Testing Market is estimated to be valued at US$ 16.15 billion in 2023 and is expected to exhibit a CAGR of 16.1% over the forecast period 2023-2030, as highlighted in a new report published by Coherent Market Insights.